Edition:
United States

Stryker Corp (SYK.N)

SYK.N on New York Stock Exchange

155.73USD
21 Nov 2017
Change (% chg)

$0.98 (+0.63%)
Prev Close
$154.75
Open
$155.76
Day's High
$156.11
Day's Low
$155.22
Volume
254,504
Avg. Vol
329,965
52-wk High
$160.60
52-wk Low
$108.30

Latest Key Developments (Source: Significant Developments)

Stryker receives U.S. FDA HDE approval for the Neuroform Atlas stent system to treat wide neck aneurysms
Thursday, 9 Nov 2017 08:30am EST 

Nov 9 (Reuters) - Stryker Corp :Stryker receives U.S. FDA HDE approval for the Neuroform Atlas™ stent system to treat wide neck aneurysms.Stryker Corp - ‍Approval allows company to begin U.S. commercialization efforts for Neuroform Atlas stent system​ immediately.  Full Article

Stryker Corp reports Q3 earnings per share $1.14
Thursday, 26 Oct 2017 04:00pm EDT 

Oct 26 (Reuters) - Stryker Corp :Stryker reports third quarter 2017 results.Sees Q4 adjusted earnings per share $1.92 to $1.97.Q3 adjusted earnings per share $1.52.Q3 earnings per share $1.14.Q3 sales $3.0 billion versus I/B/E/S view $2.97 billion.Q3 earnings per share view $1.50 -- Thomson Reuters I/B/E/S.Stryker Corp - ‍expect 2017 organic net sales growth to be in range of 6.5 pct to 7.0 pct​.Stryker Corp - ‍expect adjusted 2017 net earnings per diluted share to be in range of $6.45 to $6.50​.Fy2017 earnings per share view $6.44, revenue view $12.29 billion -- Thomson Reuters I/B/E/S.  Full Article

Stryker to acquire Vexim
Tuesday, 24 Oct 2017 04:00pm EDT 

Oct 24 (Reuters) - Stryker Corp :Stryker to acquire Vexim.Stryker Corp - ‍Stryker paid EUR 20.00 per share and EUR 3.91 per BSAAR warrant for deal​.Stryker Corp says ‍transaction is expected to be neutral to Stryker's 2017 adjusted net earnings per diluted share​.Stryker - ‍indirectly acquired securities held by some Vexim shareholders, managers, representing 50.7 pct of share capital, 50.3 pct of voting rights of co​.Stryker - deal ‍price represents equity value of Vexim on fully diluted basis of about EUR 183 million, corresponding to enterprise value of about EUR 162 million​.  Full Article

Stryker's spine division gets FDA clearance for 3d-printed tritanium c anterior cervical cage
Wednesday, 20 Sep 2017 08:02am EDT 

Sept 20 (Reuters) - Stryker Corp ::Stryker's spine division receives FDA clearance for 3d-printed tritanium® c anterior cervical cage.Stryker Corp - ‍tritanium c anterior cervical cage will be available to surgeons in Q4 2017​.  Full Article

Stryker provides update regarding Sage warning letter
Wednesday, 23 Aug 2017 08:00am EDT 

Aug 23 (Reuters) - Stryker Corp ::Reg-Stryker provides an update regarding sage warning letter and revised financial guidance.Stryker Corp says informed U.S. FDA of voluntary product recall involving specific lots of oral care products sold through sage products business unit​.Stryker - ‍recalled products contain oral care solutions manufactured for sage by third-party supplier,were distributed between July 2015 and Aug 2017​.Recall is being initiated due to a potential for cross-contamination of oral care solutions.Says ‍to date, stryker has not been made aware of any serious adverse events associated with oral care products recall​.Stryker - ‍has discontinued business with third-party supplier and all oral care solutions are being manufactured in-house by Sage​.Stryker says anticipates that adjusted net earnings per diluted share will be at lower end of its previously stated range of $1.50-$1.55 for q3​.Stryker - ‍expects to resume shipping oral care products in September and anticipates a return to full supply capacity by year end​.Says ‍there have been some reports of minor irritation and allergic reaction related to the products​.Stryker - FDA warning letter sets forth concerns regarding microbiological testing methods used for all products containing solutions sold by sage.Says ‍anticipates it will resume shipping products manufactured by sage and tested under compendial method in September​.  Full Article

Novadaq receives court approval for arrangement with Stryker
Wednesday, 9 Aug 2017 05:06pm EDT 

Aug 9 (Reuters) - Novadaq Technologies Inc :Novadaq receives court approval for arrangement with Stryker.‍Ontario superior court of justice has issued a final order approving Co's deal with Stryker corporation.‍It is expected that deal with Stryker will close in Q3 of 2017​.  Full Article

Novadaq Technologies ‍shareholders approve Stryker Corp deal
Friday, 4 Aug 2017 03:05pm EDT 

Aug 4 (Reuters) - Novadaq Technologies Inc ::Shareholders approved plan of arrangement pursuant to which Stryker Corporation will acquire all outstanding shares of co.About 98.68% of shares represented at meeting in person or by proxy, voted in favour of special resolution approving arrangement​.  Full Article

Stryker Q2 adjusted earnings per share $1.53
Thursday, 27 Jul 2017 04:01pm EDT 

July 27 (Reuters) - Stryker Corp ::Reg-Stryker reports second quarter 2017 results.Sees q3 adjusted earnings per share $1.50 to $1.55.Q2 adjusted earnings per share $1.53.Q2 earnings per share $1.03.Q2 sales $3.0 billion versus I/B/E/S view $2.98 billion.Q2 earnings per share view $1.51 -- Thomson Reuters I/B/E/S.Stryker Corp qtrly orthopaedics net sales of $1.1 billion increased 5.5 pct in quarter as reported.Stryker- ‍now expect 2017 organic net sales growth to be in range of 6.5 pct to 7.0 pct.Stryker corp says now expect 2017 organic net sales growth to be in range of 6.5 pct to 7.0 pct.Stryker corp- ‍now expect 2017 adjusted net earnings per diluted share to be in range of $6.45 to $6.55​.Stryker - if foreign currency exchange rates hold near current levels, expect net sales in q3 and full year to be negatively impacted by about 0.5 pct.Fy2017 earnings per share view $6.43, revenue view $12.23 billion -- Thomson Reuters I/B/E/S.Stryker - if foreign currency exchange rates hold near current levels, expect adjusted earnings per share to be negatively impacted by approximately $0.02 in q3.Stryker - if foreign currency exchange rates hold near current levels, expect adjusted earnings per share to be negatively impacted by approximately $0.10 in full year.  Full Article

Stryker to acquire NOVADAQ Technologies
Monday, 19 Jun 2017 08:00am EDT 

June 19 (Reuters) - Stryker Corp :Reg-Stryker announces definitive agreement to acquire novadaq technologies inc..Stryker corp - deal for us$11.75 per share.Stryker corp - transaction expected to be dilutive to stryker's 2017 adjusted net earnings per diluted share by $0.03 - $0.05.Stryker corp - for 2018, transaction is expected to be neutral to stryker's earnings and accretive thereafter.Stryker corp - no change to stryker's 2017 estimated adjusted net earnings per diluted share, which is in range of $6.35 - $6.45.Fy2017 earnings per share view $6.43 -- Thomson Reuters I/B/E/S.  Full Article

Stryker Orthopaedics 2016 settlement program reaches milestone
Monday, 8 May 2017 11:45am EDT 

May 8 (Reuters) - Stryker Corp :Reg-Stryker orthopaedics 2016 settlement program reaches milestone.Stryker corp -howmedica osteonics informed courts that 95% of additional registered eligible patients have enrolled in settlement program.Stryker corp -howmedia osteonics will move forward with 2016 settlement program that provides for compensation to additional eligible u.s. Patients.Stryker corp - expected that a majority of payments under settlement agreement will be made by end of 2017.Stryker corp - compensation for u.s. Patients replaced rejuvenate modular-neck hip stem and/or abg ii modular-neck hip stem, prior to dec 19, 2016.  Full Article

BRIEF-Stryker receives U.S. FDA HDE approval for the Neuroform Atlas stent system to treat wide neck aneurysms

* Stryker receives U.S. FDA HDE approval for the Neuroform Atlas™ stent system to treat wide neck aneurysms